2050-7771

Biomarker Research

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 775 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact775 DOIs
2

Add abstracts to 278 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact278 DOIs
3

Add license metadata to 109 records

License metadata tells indexers and readers how each article may be reused.

Low impact109 DOIs

DOIs for this ISSN

Showing the top 5 of 994 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Monocyte and macrophage differentiation: circulation inflamm… (10.1186/2050-7771-2-1)
Abstract ORCID License
222.18 916
2 Engineering CAR-T cells (10.1186/s40364-017-0102-y)
Abstract ORCID License
201.16 480
3 Bone biomarker for the clinical assessment of osteoporosis:… (10.1186/s40364-017-0097-4)
Abstract ORCID License
197.59 430
4 DNA methyltransferases and their roles in tumorigenesis (10.1186/s40364-017-0081-z)
Abstract ORCID License
188.69 327
5 Biomarkers of cytokine release syndrome and neurotoxicity re… (10.1186/s40364-018-0116-0)
Abstract ORCID License
178.65 240
6 CD 123 is a membrane biomarker and a therapeutic target in h… (10.1186/2050-7771-2-4)
Abstract ORCID License
175.98 221
7 Machine learning and systems genomics approaches for multi-o… (10.1186/s40364-017-0082-y)
Abstract ORCID License
166.70 166
8 Critical appraisal of the role of serum albumin in cardiovas… (10.1186/s40364-017-0111-x)
Abstract ORCID License
165.91 162
9 Utility of PD-L1 immunohistochemistry assays for predicting… (10.1186/s40364-017-0093-8)
Abstract ORCID License
165.31 159
10 Nephrin – a biomarker of early glomerular injury (10.1186/2050-7771-2-21)
Abstract ORCID License
150.00 99
11 Fluorescence in situ hybridization (FISH): an increasingly d… (10.1186/2050-7771-2-3)
Abstract ORCID License
146.20 88
12 MicroRNAs as promising biomarkers in cancer diagnostics (10.1186/2050-7771-2-19)
Abstract ORCID License
144.32 83
13 Dental implant bioactive surface modifications and their eff… (10.1186/s40364-016-0078-z)
Abstract ORCID License
143.14 80
14 Tumor-associated macrophages, potential targets for cancer t… (10.1186/s40364-017-0106-7)
Abstract ORCID License
136.47 65
15 Elevation of brain-enriched miRNAs in cerebrospinal fluid of… (10.1186/s40364-017-0104-9)
Abstract ORCID License
135.97 64
16 DNA methylation: potential biomarker in Hepatocellular Carci… (10.1186/2050-7771-2-5)
Abstract ORCID License
129.32 52
17 Exosomes from mesenchymal stem/stromal cells: a new therapeu… (10.1186/s40364-019-0159-x)
Abstract ORCID
126.89 344
18 A panel of glycoproteins as candidate biomarkers for early d… (10.1186/s40364-016-0055-6)
Abstract ORCID License
125.41 46
19 Pan-cancer analysis of genomic scar signatures associated wi… (10.1186/s40364-015-0033-4)
Abstract ORCID
121.00 262
20 CD34 and CD38 are prognostic biomarkers for acute B lymphobl… (10.1186/s40364-016-0080-5)
Abstract ORCID License
120.15 39
21 Metastatic biomarkers in synovial sarcoma (10.1186/s40364-017-0083-x)
Abstract ORCID License
116.72 35
22 Novel biomarkers for diagnosis, prognosis, targeted therapy… (10.1186/2050-7771-1-1)
Abstract ORCID License
115.81 34
23 Circulating micrornas associated with glycemic impairment an… (10.1186/s40364-015-0047-y)
Abstract ORCID License
115.81 34
24 Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SN… (10.1186/2050-7771-2-18)
Abstract ORCID License
114.86 33
25 SALL4 as a transcriptional and epigenetic regulator in norma… (10.1186/s40364-017-0115-6)
Abstract ORCID License
114.86 33
26 High expression of RNA-binding motif protein 3 in esophageal… (10.1186/2050-7771-2-11)
Abstract ORCID License
113.89 32
27 Diagnosis and treatment of CD20 negative B cell lymphomas (10.1186/s40364-017-0088-5)
Abstract ORCID License
113.89 32
28 Circumventing qPCR inhibition to amplify miRNAs in plasma (10.1186/2050-7771-2-13)
Abstract ORCID License
112.89 31
29 SOX11 is a biomarker for cyclin D1-negative mantle cell lymp… (10.1186/s40364-016-0060-9)
Abstract ORCID License
111.85 30
30 Update on the first-line treatment for Helicobacter pylori i… (10.1186/s40364-017-0103-x)
Abstract ORCID License
111.85 30
31 Protein kinase inhibitors for acute leukemia (10.1186/s40364-018-0123-1)
Abstract ORCID License
111.85 30
32 Micro-RNAs, New performers in multiple myeloma bone marrow m… (10.1186/2050-7771-2-10)
Abstract ORCID License
110.78 29
33 Expression of IFITM1 as a prognostic biomarker in resected g… (10.1186/s40364-016-0064-5)
Abstract ORCID License
109.68 28
34 Dysregulation of JAK-STAT pathway in hematological malignanc… (10.1186/2050-7771-1-5)
ORCID License
108.95 150
35 Development of TAP, a non-invasive test for qualitative and… (10.1186/2050-7771-2-20)
Abstract ORCID License
108.54 27
36 The CXCR4 antagonist plerixafor enhances the effect of ritux… (10.1186/s40364-016-0067-2)
Abstract ORCID License
108.54 27
37 Advance in microRNA as a potential biomarker for early detec… (10.1186/s40364-016-0074-3)
Abstract ORCID License
108.54 27
38 Burden of hepatocellular carcinoma among hispanics in South… (10.1186/s40364-017-0096-5)
Abstract ORCID License
108.54 27
39 Therapeutic potential of folic acid supplementation for card… (10.1186/s40364-015-0049-9)
Abstract ORCID License
107.35 26
40 A robust prognostic gene expression signature for early stag… (10.1186/s40364-016-0058-3)
Abstract ORCID License
107.35 26
41 The resistance mechanisms of proteasome inhibitor bortezomib (10.1186/2050-7771-1-13)
Abstract ORCID
106.84 136
42 Tolerability to romidepsin in patients with relapsed/refract… (10.1186/2050-7771-2-16)
Abstract ORCID License
106.12 25
43 Novel insights into MSC-EVs therapy for immune diseases (10.1186/s40364-019-0156-0)
Abstract ORCID
105.19 126
44 Statins inhibit proliferation and cytotoxicity of a human le… (10.1186/2050-7771-1-33)
Abstract ORCID License
104.85 24
45 Autoimmune hemolytic anemia associated with babesiosis (10.1186/s40364-017-0095-6)
Abstract ORCID License
103.52 23
46 Multicenter phase II clinical trial of nilotinib for patient… (10.1186/2050-7771-2-6)
Abstract ORCID License
102.13 22
47 Ruxolitinib improves symptoms and quality of life in a patie… (10.1186/s40364-016-0056-5)
Abstract ORCID License
102.13 22
48 A novel three-way rearrangement involving ETV6 (12p13) and A… (10.1186/s40364-016-0070-7)
Abstract ORCID License
100.68 21
49 The effect of n-3 polyunsaturated fatty acids on incidence a… (10.1186/s40364-016-0066-3)
Abstract ORCID License
97.58 19
50 Urinary biomarkers for early diabetic nephropathy in type 2… (10.1186/s40364-015-0042-3)
Abstract ORCID
97.47 88